Literature DB >> 17146385

Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas?

Han-Sin Jeong1, Manki Chung, Chung-Hwan Baek, Young-Hyeh Ko, Joon-Young Choi, Young-Ik Son.   

Abstract

OBJECTIVE: To evaluate the hypothesis that the [F]-fluorodeoxyglucose (FDG) standardized uptake values (SUVs) of positron emission tomographic (PET) imaging can predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas (TPMC)
DESIGN: Prospective clinical study.
METHOD: From 2004 to 2005, 44 consecutive patients with TPMC (< or =1 cm), confirmed by ultrasonography and aspiration cytology, had FDG PET scans performed. Among them, 66 tumor foci in 41 patients were confirmed to be of less than 1 cm in diameter by the final surgical pathology report. According to the microcarcinoma tumor focus, prediction of pathologic extrathyroid invasion, by clinical variables including sonographic findings and SUVs from PET imaging, was evaluated by the univariate and multivariate logistic regression analysis.
RESULTS: : Univariate analysis showed that the tumor site attached to the thyroid capsule and the SUVs of PET imaging could predict pathologic extrathyroid invasion. However, the tumor site attached to thyroid capsule and an age older than 45 were significant predictors by multivariate analysis (P = .001 and P = .036). SUVs from PET imaging were only correlated with the size of tumor (P < 0.001).
CONCLUSION: The SUVs from FDG PET imaging alone cannot predict the pathologic extrathyroid invasion in patients with TPMC. However, the ultrasonographic findings, such as tumor site, provide better information about the extrathyroid invasion of TPMC tumor foci.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146385     DOI: 10.1097/01.mlg.0000243043.65560.3f

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.

Authors:  Heejin Kim; Kyung Jin Na; Jae Hyuk Choi; Byeong-Cheol Ahn; Dongbin Ahn; Jin Ho Sohn
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

2.  Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.

Authors:  Bum Soo Kim; Seong-Jang Kim; In Joo Kim; Kyounjune Pak; Keunyoung Kim
Journal:  Thyroid       Date:  2012-04-23       Impact factor: 6.568

3.  Association Between (18)F-FDG Avidity and the BRAF Mutation in Papillary Thyroid Carcinoma.

Authors:  Suk Hyun Lee; Sangwon Han; Hyo Sang Lee; Sun Young Chae; Jong Jin Lee; Dong Eun Song; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2015-09-22

4.  The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Prognostication, Diagnosis, and Management of Thyroid Carcinoma.

Authors:  Brian Hung-Hin Lang
Journal:  J Thyroid Res       Date:  2011-10-09

5.  High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma.

Authors:  Bo Hyun Kim; Seong-Jang Kim; Keunyoung Kim; Heeyoung Kim; So Jung Kim; Won Jin Kim; Yun Kyung Jeon; Sang Soo Kim; Yong Ki Kim; In Joo Kim
Journal:  Ann Nucl Med       Date:  2015-06-25       Impact factor: 2.668

6.  Clinical significance of miR-34a expression in thyroid diseases - an 18F-FDG PET-CT study.

Authors:  Long Chen; Conghui Yang; Jun Feng; Xin Liu; Yadong Tian; Lei Zhao; Ran Xie; Chao Liu; Sheng Zhao; Hua Sun
Journal:  Cancer Manag Res       Date:  2017-12-15       Impact factor: 3.989

7.  Comparison of Natural Course between Thyroid Cancer Nodules and Thyroid Benign Nodules.

Authors:  Kyun Jin Yun; Jeonghoon Ha; Min Hee Kim; Ye Young Seo; Mee Kyoung Kim; Hyuk Sang Kwon; Ki Ho Song; Moo Il Kang; Ki Hyun Baek
Journal:  Endocrinol Metab (Seoul)       Date:  2019-06

8.  Comparison of two- and three-dimensional sonography for the prediction of the extrathyroidal extension of papillary thyroid carcinomas.

Authors:  Yang Seon Yi; Sang Soo Kim; Won Jin Kim; Min Jung Bae; Ji Hyun Kang; Bo Gwang Choi; Yun Kyung Jeon; Bo Hyun Kim; Byung Joo Lee; Soo Geun Wang; In Joo Kim; Yong Ki Kim
Journal:  Korean J Intern Med       Date:  2015-12-23       Impact factor: 2.884

9.  Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT.

Authors:  Ari Chong; Jung-Min Ha; Yeon-Hee Han; Eunjung Kong; Yunjung Choi; Ki Hwan Hong; Jun-Hee Park; Sung Hoon Kim; Jung Mi Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-06-18       Impact factor: 3.372

10.  Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.

Authors:  Seokho Yoon; Young-Sil An; Su Jin Lee; Eu Young So; Jang-Hee Kim; Yoon-Sok Chung; Joon-Kee Yoon
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.